Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses

NCT01779102 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

456

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: C-Tb
BIOLOGICAL: Tuberculin PPD RT 23 SSI
BIOLOGICAL: C-Tb / Tuberculin PPD RT 23 SSI

Sponsor

Statens Serum Institut